ROLKE JAMES (Chief Executive Officer) received a stock award from REVELATION BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/31/2025ACC: 0001193125-25-260423
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+390.61K
Net shares
Net buyer
$500.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
390.61K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+390.61K
Price / share
$1.28
Trade value
$499.99K
% of position
3888.3%
10/29/2025
10.05K→400.66K
Total
Net shares
+390.61K
Net value
$499.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/29/2025 | A · Award | +390.61K | $1.28 | $499.99K | 3888.3% | 10.05K | 400.66K |
| Total | +390.61K | $499.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned10.05K
Total
10.05K direct10.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.05K | Direct |
| Total | 10.05K | 10.05K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported